Bionexus Gene Lab (BGLC) - 2023 Q4 - Annual Report

39 Table of Contents Terms of Directors and Officers Our officers are elected by and serve at the discretion of the board of directors and the stockholders voting by ordinary resolution. Compensation of Directors and Executive Officers For the year ended December 31, 2023, we paid an aggregate of approximately $30,000 including 25,000 shares valued at $25,000, respectively, in cash and benefits to our executive officers. We do not have a share incentive program to provide for grants of awards to our directo ...